Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Watch and wait in rectal cancer patients with residual mucin on magnetic resonance imaging following neoadjuvant therapy.
Judge SJ, Malekzadeh P, Corines MJ, Gollub MJ, Horvat N, Gonen M, Saltz L, Cercek A, Romesser P, Crane C, Shia J, Wei I, Widmar M, Pappou E, Nash GM, Smith JJ, Paty PB, Garcia-Aguilar J, Weiser MR. Judge SJ, et al. Among authors: malekzadeh p. J Natl Cancer Inst. 2024 Nov 1;116(11):1761-1766. doi: 10.1093/jnci/djae152. J Natl Cancer Inst. 2024. PMID: 38937278
Adjuvant therapy for stage IIB + IIC melanoma.
Malekzadeh P, Brady MS. Malekzadeh P, et al. J Surg Oncol. 2024 Jan;129(1):91-96. doi: 10.1002/jso.27534. Epub 2023 Nov 30. J Surg Oncol. 2024. PMID: 38031847 No abstract available.
Metabolic risk factors attributed burden in Iran at national and subnational levels, 1990 to 2019.
Moradi S, Parsaei A, Saeedi Moghaddam S, Aryannejad A, Azadnajafabad S, Rezaei N, Mashinchi B, Esfahani Z, Shobeiri P, Rezaei N; GBD 2019 Iran MRF Collaborators; Naghavi M, Larijani B, Farzadfar F. Moradi S, et al. Front Public Health. 2023 Jun 1;11:1149719. doi: 10.3389/fpubh.2023.1149719. eCollection 2023. Front Public Health. 2023. PMID: 37325329 Free PMC article.
Internal checkpoint regulates T cell neoantigen reactivity and susceptibility to PD1 blockade.
Palmer DC, Webber BR, Patel Y, Johnson MJ, Kariya CM, Lahr WS, Parkhurst MR, Gartner JJ, Prickett TD, Lowery FJ, Kishton RJ, Gurusamy D, Franco Z, Vodnala SK, Diers MD, Wolf NK, Slipek NJ, McKenna DH, Sumstad D, Viney L, Henley T, Bürckstümmer T, Baker O, Hu Y, Yan C, Meerzaman D, Padhan K, Lo W, Malekzadeh P, Jia L, Deniger DC, Patel SJ, Robbins PF, McIvor RS, Choudhry M, Rosenberg SA, Moriarity BS, Restifo NP. Palmer DC, et al. Among authors: malekzadeh p. Med. 2022 Oct 14;3(10):682-704.e8. doi: 10.1016/j.medj.2022.07.008. Epub 2022 Aug 24. Med. 2022. PMID: 36007524 Free PMC article.
Cancer genes disfavoring T cell immunity identified via integrated systems approach.
Kishton RJ, Patel SJ, Decker AE, Vodnala SK, Cam M, Yamamoto TN, Patel Y, Sukumar M, Yu Z, Ji M, Henning AN, Gurusamy D, Palmer DC, Stefanescu RA, Girvin AT, Lo W, Pasetto A, Malekzadeh P, Deniger DC, Wood KC, Sanjana NE, Restifo NP. Kishton RJ, et al. Among authors: malekzadeh p. Cell Rep. 2022 Aug 2;40(5):111153. doi: 10.1016/j.celrep.2022.111153. Cell Rep. 2022. PMID: 35926468 Free PMC article.
Adoptive Cellular Therapy with Autologous Tumor-Infiltrating Lymphocytes and T-cell Receptor-Engineered T Cells Targeting Common p53 Neoantigens in Human Solid Tumors.
Kim SP, Vale NR, Zacharakis N, Krishna S, Yu Z, Gasmi B, Gartner JJ, Sindiri S, Malekzadeh P, Deniger DC, Lowery FJ, Parkhurst MR, Ngo LT, Ray S, Li YF, Hill V, Florentin M, Masi RV, Paria BC, Levin N, Bera A, Hedges EA, Choi A, Chatani PD, Parikh AY, Levi S, Seitter S, Lu YC, Zheng Z, Prickett TD, Jia L, Hernandez JM, Hoang CD, Robbins PF, Goff SL, Sherry RM, Yang JC, Rosenberg SA. Kim SP, et al. Among authors: malekzadeh p. Cancer Immunol Res. 2022 Aug 3;10(8):932-946. doi: 10.1158/2326-6066.CIR-22-0040. Cancer Immunol Res. 2022. PMID: 35749374 Free PMC article.
40 results